New antimicrobial strategy silences NDM-1 resistance gene in pathogens

September 8, 2014, American Society for Microbiology

Researchers have synthesized a molecule that can silence the gene responsible for severe antibiotic resistance in some bacteria. The research, presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), an infectious disease meeting of the American Society for Microbiology (ASM) could be a viable new strategy for treating resistant infections.

The focus of this new molecule is NDM-1 (New Delhi metallo-beta-lactamase-1) a gene carried by some bacteria that allows them to produce an enzyme called carbapenemase.

"NDM-1 confers bacterial resistance to all classes of beta-lactam (penicillin type) antibiotics including carbapenems, powerful antibiotics used when others fail," says Bruce Geller of Oregon State University and author on the study. "NDM-1 has spread rapidly to many bacterial pathogens, including E. coli, Acinetobacter baumannii and Klebsiella pneumoniae. Many of these pathogens are resistant to multiple , which limits treatment options."

Molecule known as a peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) are synthetic analogs of DNA or RNA that have the ability to silence the expression of specific genes. In this study Geller and his colleagues at Oregon State University and the University of Texas Southwestern have design, synthesized and tested a PPMO that is complimentary to the NDM-1 gene, allowing it to bind specifically to NDM-1 mRNA, essentially silencing the gene.

"When the NDM-1 PPMO was added to growing cultures of multidrug-resistant E. coli, A. baumannii or K. pneumoniae that express NDM-1, it restored susceptibility to carbapenems at therapeutically relevant concentrations," says Geller.

NDM-1 infection was first identified in 2009 in people who resided in or traveled to the India and Pakistan. The first cases in the United States were identified in 2010, and the number of cases is growing. The concern is that these highly carrying NDM-1 could supplant more antibiotic-sensitive strains.

"There is a critical need to find new treatments for antibiotic-resistant pathogens and using a gene-silencing approach, such as with a PPMO, could be one viable strategy for new antimicrobial development," says Geller.

Explore further: Team unearths what may be secret weapon against antibiotic resistance

More information: This research was presented as part of the ASM's 54th ICAAC held September 5-9, 2014 in Washington, DC.

Related Stories

Team unearths what may be secret weapon against antibiotic resistance

June 25, 2014
A fungus living in the soils of Nova Scotia could offer new hope in the pressing battle against drug-resistant germs that kill tens of thousands of people every year, including one considered a serious global threat.

Inexpensive lab test identifies resistant infections in hours

September 7, 2014
Researchers from Oregon State Public Health Lab have modified the protocol for a relatively new test for a dangerous form of antibiotic resistance, increasing its specificity to 100 percent. Their research, confirming the ...

New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada

May 30, 2011
An enzyme associated with extensive antibiotic resistance called New Delhi metallo-ß-lactamase-1 (NDM-1), endemic in India and Pakistan and spreading worldwide, has been found in two people in the Toronto area, one of ...

Recommended for you

Dengue: Investigating antibodies to identify at-risk individuals

May 23, 2018
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus ...

Fatty liver disease research set to benefit from stem cell advance

May 23, 2018
Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

More frequent checks control MRSA in newborns, but can hospitals afford them?

May 22, 2018
The more often a hospital can check its newborns for deadly MRSA germs, the more likely it will be that they are contained, according to a new study.

Could we predict the next Ebola outbreak by tracking the migratory patterns of bats?

May 22, 2018
Javier Buceta, associate professor of bioengineering, Paolo Bocchini, associate professor of civil and environmental engineering, and postdoctoral student Graziano Fiorillo of Lehigh University have created a modeling framework ...

Helping preterm infants grow bigger kidneys would prevent kidney disease later in life

May 21, 2018
Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Kidney docs worry over no dialysis for undocumented immigrants

May 21, 2018
(HealthDay)—Undocumented immigrants in the United States are often denied treatment for kidney failure until they have a life-threatening emergency. Now a new study finds that the doctors and nurses who treat them are frustrated ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.